← Every applicant
Sun Pharm FDA Approvals
26 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| VOBRIGNew drugAug 26, 2026SOLUTION, SUBCUTANEOUS |
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATENew drugJun 3, 2026CAPSULE, ORAL |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDENew drugApr 6, 2026TABLET, EXTENDED RELEASE, ORAL |
| MACITENTANNew drugAug 26, 2025TABLET, ORAL |
| DEFLAZACORTNew drugMar 18, 2025TABLET, ORAL |
| SELENIOUS ACIDNew drugFeb 20, 2025SOLUTION, INTRAVENOUS |
| BYNFEZIA PENNew drugSep 27, 2024SOLUTION, SUBCUTANEOUS |
| PAZOPANIB HYDROCHLORIDENew drugOct 19, 2023TABLET, ORAL |
| LOTEPREDNOL ETABONATENew drugAug 9, 2023GEL, OPHTHALMIC |
| SAXAGLIPTIN AND METFORMIN HYDROCHLORIDENew drugJul 31, 2023TABLET, EXTENDED RELEASE, ORAL |
| SAXAGLIPTINNew drugJul 31, 2023TABLET, ORAL |
| ERTAPENEM SODIUMNew drugMay 2, 2023INJECTABLE, INTRAMUSCULAR, INTRAVENOUS |
| LENALIDOMIDENew drugFeb 8, 2023CAPSULE, ORAL |
| CARIPRAZINE HYDROCHLORIDENew drugSep 30, 2022CAPSULE, ORAL |
| CIPROFLOXACIN AND DEXAMETHASONENew drugAug 30, 2022SUSPENSION/DROPS, OTIC |
| ARFORMOTEROL TARTRATENew drugMay 26, 2022SOLUTION, INHALATION |
| MESALAMINENew drugMay 11, 2022CAPSULE, EXTENDED RELEASE, ORAL |
| LACOSAMIDENew drugMar 17, 2022TABLET, ORAL |
| SUNITINIB MALATENew drugAug 16, 2021CAPSULE, ORAL |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDENew drugJul 1, 2021TABLET, EXTENDED RELEASE, ORAL |
| BUDESONIDENew drugApr 14, 2021SUSPENSION, INHALATION |
| PREGABALINNew drugApr 13, 2021TABLET, EXTENDED RELEASE, ORAL |
| LOTEPREDNOL ETABONATENew drugFeb 26, 2021SUSPENSION/DROPS, OPHTHALMIC |
| DROXIDOPANew drugFeb 18, 2021CAPSULE, ORAL |
| NOREPINEPHRINE BITARTRATENew drugJan 29, 2021INJECTABLE, INJECTION |
| EPOPROSTENOL SODIUMNew drugJan 15, 2021INJECTABLE, INJECTION |